Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of Self-amplifying mRNA Vaccine for Rapid Pandemic Influenza Response
Stock Information for Arcturus Therapeutics Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.